These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21728169)

  • 1. Differential requirement of IKK2 for CYLD-dependent representation of thymic and peripheral T-cell populations.
    Tsagaratou A; Grammenoudi S; Mosialos G
    Eur J Immunol; 2011 Oct; 41(10):3054-62. PubMed ID: 21728169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner.
    Tsagaratou A; Trompouki E; Grammenoudi S; Kontoyiannis DL; Mosialos G
    J Immunol; 2010 Aug; 185(4):2032-43. PubMed ID: 20644164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice.
    Zhang J; Stirling B; Temmerman ST; Ma CA; Fuss IJ; Derry JM; Jain A
    J Clin Invest; 2006 Nov; 116(11):3042-9. PubMed ID: 17053834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressor CYLD controls the function of murine regulatory T cells.
    Reissig S; Hövelmeyer N; Weigmann B; Nikolaev A; Kalt B; Wunderlich TF; Hahn M; Neurath MF; Waisman A
    J Immunol; 2012 Nov; 189(10):4770-6. PubMed ID: 23066153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutated cylindromatosis gene affects the functional state of dendritic cells.
    Bros M; Dexheimer N; Besche V; Masri J; Trojandt S; Hövelmeyer N; Reissig S; Massoumi R; Grabbe S; Waisman A; Reske-Kunz AB
    Eur J Immunol; 2010 Oct; 40(10):2848-57. PubMed ID: 20836156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of CYLD might be associated with development of salivary gland tumors.
    Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
    Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
    Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
    Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
    Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
    Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lack of NF-kappa B transactivation and PKC epsilon expression in CD4(+)CD8(+) thymocytes correlates with negative selection.
    Simon AK; Auphan N; Pophillat M; Boyer C; Ghosh S; Rincón M; Flavell RA; Schmitt-Verhulst AM
    Cell Death Differ; 2000 Dec; 7(12):1253-62. PubMed ID: 11175263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein phosphatase subunit G5PR that regulates the JNK-mediated apoptosis signal is essential for the survival of CD4 and CD8 double-positive thymocytes.
    Xing Y; Wang X; Igarashi H; Kawamoto H; Sakaguchi N
    Mol Immunol; 2008 Apr; 45(7):2028-37. PubMed ID: 18022237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.
    Massoumi R; Chmielarska K; Hennecke K; Pfeifer A; Fässler R
    Cell; 2006 May; 125(4):665-77. PubMed ID: 16713561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
    Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
    Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential role of the transcription factor NF-kappaB in selection and survival of CD4+ and CD8+ thymocytes.
    Jimi E; Strickland I; Voll RE; Long M; Ghosh S
    Immunity; 2008 Oct; 29(4):523-37. PubMed ID: 18957265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CYLD, NF-kappaB and NF-kappaB-related factors in salivary gland tumors.
    Fukuda M; Fukuda F; Horiuchi Y; Oku Y; Suzuki S; Kusama K; Sakashita H
    In Vivo; 2006; 20(4):467-72. PubMed ID: 16900776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.
    Liu S; Lv J; Han L; Ichikawa T; Wang W; Li S; Wang XL; Tang D; Cui T
    Biochem Biophys Res Commun; 2012 Mar; 420(1):78-83. PubMed ID: 22406061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
    Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO
    Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYLD: a multifunctional deubiquitinase.
    Glittenberg M; Ligoxygakis P
    Fly (Austin); 2007; 1(6):330-2. PubMed ID: 18820455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of NF-kappaB-dependent T cell activation and development by MEKK3.
    Shinohara H; Yamasaki S; Maeda S; Saito T; Kurosaki T
    Int Immunol; 2009 Apr; 21(4):393-401. PubMed ID: 19223432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the NF-kappaB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKalpha.
    Malinge S; Monni R; Bernard O; Penard-Lacronique V
    Oncogene; 2006 Jun; 25(25):3589-97. PubMed ID: 16434962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells.
    Jin W; Reiley WR; Lee AJ; Wright A; Wu X; Zhang M; Sun SC
    J Biol Chem; 2007 May; 282(21):15884-93. PubMed ID: 17392286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.